Company profile · Apotheek
TS Vascular
- Employees
- 2–10
- Founded
- 2024
- Province
- Groningen
- Country
- Netherlands
About TS Vascular
TS Vascular is a clinical staged company developing a patented oral tablet of Sodium Thiosulfate (STS) for chronic treatment of cardiovascular diseases. Until now, STS could only be given intravenously, limiting its potential despite strong preclinical data. Our unique formulation protects STS in the stomach and releases it in the intestine, enabling effective oral use at home. The first clinical trial, supported by Vroege Fase Financiering, will start in November 2025 and test STS as a novel therapy for Raynaud’s phenomenon
Address
Headquarters
GroningenGroningen, Netherlands
Team by function
Based on 1 public job profiles as of 3 September 2026.
- Finance / Accounting1
Similar companies
Companies with a similar profile, Groningen first.
Sulfateq B.V.
Pharmaceuticals · Groningen
11–50 employeesView profile
STENTiT
Medical Devices · Eindhoven
2–10 employeesView profile
TargED Biopharmaceuticals
Biotechnology · Utrecht
11–50 employeesView profile
Total-MS (Total Medical Solutions BV )
Hospital & Health Care · Dordrecht
2–10 employeesView profile
VitroScan
Biotechnology · Leiden
2–10 employeesView profile
ToxGenSolutions BV TGS
Biotechnology · Maastricht
11–50 employeesView profile